Article
Histological analysis of IL-2 induced regression of murine solid SL2-tumors.
Biotherapy (Dordrecht, Netherlands) - 1 Jan 1993
Maas R A, Dullens H F, Henk D, Van Weering J, De Mik H J, Koten J W, Belger R J, Den Otter W
Abstract excerpt
When DBA/2 mice are inoculated both intraperitoneally (i.p.) and subcutaneously (s.c.) with syngeneic SL2 lymphoma cells and treated i.p. on day 10-14 with 20,000 units IL-2/day, about 50% of the mice reject both the ascitic tumour and the s.c. tumour. During IL-2 therapy large areas of necrosis...
Topics
- Animals
- CD4-Positive T-Lymphocytes
- Dose-Response Relationship, Drug
- Immunohistochemistry
- Injections, Intraperitoneal
- Injections, Subcutaneous
- Interleukin-2
- Lymphocytes, Tumor-Infiltrating
- Lymphoma, T-Cell
- Macrophages, Peritoneal
- Male
- Mice
- Mice, Inbred DBA
- Neoplasm Transplantation
- Phenotype
- Recombinant Proteins